vs
PILGRIMS PRIDE CORP（PPC）与TENET HEALTHCARE CORP（THC）财务数据对比。点击上方公司名可切换其他公司
TENET HEALTHCARE CORP的季度营收约是PILGRIMS PRIDE CORP的1.2倍（$5.5B vs $4.5B），TENET HEALTHCARE CORP净利率更高（11.7% vs 2.2%，领先9.4%），TENET HEALTHCARE CORP同比增速更快（9.0% vs 1.6%），过去两年TENET HEALTHCARE CORP的营收复合增速更高（1.5% vs -0.3%）
Pilgrim's Pride是美国跨国食品企业，为美国及波多黎各最大的鸡肉生产商之一，同时是墨西哥第二大鸡肉生产商。公司2009年12月脱离破产状态，2011年将美国总部迁至科罗拉多州格里利，由JBS集团控股，2016年11月底以3.5亿美元收购Gold'n Plump。
Tenet Healthcare Corporation是总部位于美国达拉斯的营利性跨国医疗服务企业，旗下拥有USPI等多个品牌、子公司、合资企业及合作主体，运营65家医院及超过450个医疗设施，还通过旗下Conifer Health Solutions为各类医疗系统及其他客户提供专业医疗支持服务
PPC vs THC — 直观对比
营收规模更大
THC
是对方的1.2倍
$4.5B
营收增速更快
THC
高出7.4%
1.6%
净利率更高
THC
高出9.4%
2.2%
两年增速更快
THC
近两年复合增速
-0.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $4.5B | $5.5B |
| 净利润 | $101.5M | $644.0M |
| 毛利率 | 7.6% | — |
| 营业利润率 | 3.6% | 15.4% |
| 净利率 | 2.2% | 11.7% |
| 营收同比 | 1.6% | 9.0% |
| 净利润同比 | — | 12.6% |
| 每股收益（稀释后） | $0.43 | $4.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PPCTHC
| Q1 26 | $4.5B | — | ||
| Q4 25 | $4.5B | $5.5B | ||
| Q3 25 | $4.8B | $5.3B | ||
| Q2 25 | $4.8B | $5.3B | ||
| Q1 25 | $4.5B | $5.2B | ||
| Q4 24 | $4.4B | $5.1B | ||
| Q3 24 | $4.6B | $5.1B | ||
| Q2 24 | $4.6B | $5.1B |
净利润PPCTHC
| Q1 26 | $101.5M | — | ||
| Q4 25 | $88.0M | $644.0M | ||
| Q3 25 | $342.8M | $579.0M | ||
| Q2 25 | $355.5M | $522.0M | ||
| Q1 25 | $296.0M | $622.0M | ||
| Q4 24 | $235.9M | $572.0M | ||
| Q3 24 | $349.9M | $681.0M | ||
| Q2 24 | $326.3M | $477.0M |
毛利率PPCTHC
| Q1 26 | 7.6% | — | ||
| Q4 25 | 9.5% | — | ||
| Q3 25 | 13.9% | — | ||
| Q2 25 | 15.0% | — | ||
| Q1 25 | 12.4% | — | ||
| Q4 24 | 12.7% | — | ||
| Q3 24 | 14.9% | — | ||
| Q2 24 | 15.2% | — |
营业利润率PPCTHC
| Q1 26 | 3.6% | — | ||
| Q4 25 | 4.5% | 15.4% | ||
| Q3 25 | 10.4% | 16.8% | ||
| Q2 25 | 10.8% | 15.6% | ||
| Q1 25 | 9.1% | 18.1% | ||
| Q4 24 | 7.0% | 16.2% | ||
| Q3 24 | 11.1% | 21.3% | ||
| Q2 24 | 9.7% | 14.9% |
净利率PPCTHC
| Q1 26 | 2.2% | — | ||
| Q4 25 | 1.9% | 11.7% | ||
| Q3 25 | 7.2% | 10.9% | ||
| Q2 25 | 7.5% | 9.9% | ||
| Q1 25 | 6.6% | 11.9% | ||
| Q4 24 | 5.4% | 11.3% | ||
| Q3 24 | 7.6% | 13.3% | ||
| Q2 24 | 7.2% | 9.3% |
每股收益（稀释后）PPCTHC
| Q1 26 | $0.43 | — | ||
| Q4 25 | $0.37 | $4.22 | ||
| Q3 25 | $1.44 | $3.86 | ||
| Q2 25 | $1.49 | $3.14 | ||
| Q1 25 | $1.24 | $4.27 | ||
| Q4 24 | $1.00 | $3.79 | ||
| Q3 24 | $1.47 | $4.89 | ||
| Q2 24 | $1.37 | $2.64 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $542.4M | $2.9B |
| 总债务越低越好 | $3.1B | $13.1B |
| 股东权益账面价值 | $3.7B | $4.2B |
| 总资产 | $10.2B | $29.7B |
| 负债/权益比越低杠杆越低 | 0.83× | 3.10× |
8季度趋势，按日历期对齐
现金及短期投资PPCTHC
| Q1 26 | $542.4M | — | ||
| Q4 25 | $640.2M | $2.9B | ||
| Q3 25 | $612.6M | $3.0B | ||
| Q2 25 | $849.0M | $2.6B | ||
| Q1 25 | $2.1B | $3.0B | ||
| Q4 24 | $2.0B | $3.0B | ||
| Q3 24 | $1.9B | $4.1B | ||
| Q2 24 | $1.3B | $2.9B |
总债务PPCTHC
| Q1 26 | $3.1B | — | ||
| Q4 25 | $3.1B | $13.1B | ||
| Q3 25 | $3.1B | $13.1B | ||
| Q2 25 | $3.1B | $13.1B | ||
| Q1 25 | $3.2B | $13.1B | ||
| Q4 24 | $3.2B | $13.1B | ||
| Q3 24 | $3.2B | $12.8B | ||
| Q2 24 | $3.2B | $12.8B |
股东权益PPCTHC
| Q1 26 | $3.7B | — | ||
| Q4 25 | $3.7B | $4.2B | ||
| Q3 25 | $3.5B | $4.0B | ||
| Q2 25 | $3.7B | $3.7B | ||
| Q1 25 | $3.1B | $4.2B | ||
| Q4 24 | $4.2B | $4.2B | ||
| Q3 24 | $4.2B | $3.8B | ||
| Q2 24 | $3.7B | $3.5B |
总资产PPCTHC
| Q1 26 | $10.2B | — | ||
| Q4 25 | $10.3B | $29.7B | ||
| Q3 25 | $10.0B | $29.4B | ||
| Q2 25 | $10.1B | $28.7B | ||
| Q1 25 | $11.0B | $29.2B | ||
| Q4 24 | $10.7B | $28.9B | ||
| Q3 24 | $10.7B | $29.4B | ||
| Q2 24 | $10.1B | $29.3B |
负债/权益比PPCTHC
| Q1 26 | 0.83× | — | ||
| Q4 25 | 0.84× | 3.10× | ||
| Q3 25 | 0.87× | 3.26× | ||
| Q2 25 | 0.83× | 3.49× | ||
| Q1 25 | 1.02× | 3.13× | ||
| Q4 24 | 0.76× | 3.14× | ||
| Q3 24 | 0.76× | 3.33× | ||
| Q2 24 | 0.85× | 3.67× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $731.0M |
| 自由现金流经营现金流 - 资本支出 | — | $367.0M |
| 自由现金流率自由现金流/营收 | — | 6.6% |
| 资本支出强度资本支出/营收 | — | 6.6% |
| 现金转化率经营现金流/净利润 | — | 1.14× |
| 过去12个月自由现金流最近4个季度 | — | $2.5B |
8季度趋势，按日历期对齐
经营现金流PPCTHC
| Q1 26 | — | — | ||
| Q4 25 | $291.2M | $731.0M | ||
| Q3 25 | $458.3M | $1.1B | ||
| Q2 25 | $495.2M | $936.0M | ||
| Q1 25 | $126.9M | $815.0M | ||
| Q4 24 | $349.3M | $-331.0M | ||
| Q3 24 | $651.1M | $1.0B | ||
| Q2 24 | $718.6M | $747.0M |
自由现金流PPCTHC
| Q1 26 | — | — | ||
| Q4 25 | $10.0M | $367.0M | ||
| Q3 25 | $275.9M | $778.0M | ||
| Q2 25 | $339.1M | $743.0M | ||
| Q1 25 | $28.1M | $642.0M | ||
| Q4 24 | $176.6M | $-661.0M | ||
| Q3 24 | $565.3M | $829.0M | ||
| Q2 24 | $617.7M | $602.0M |
自由现金流率PPCTHC
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 6.6% | ||
| Q3 25 | 5.8% | 14.7% | ||
| Q2 25 | 7.1% | 14.1% | ||
| Q1 25 | 0.6% | 12.3% | ||
| Q4 24 | 4.0% | -13.0% | ||
| Q3 24 | 12.3% | 16.2% | ||
| Q2 24 | 13.5% | 11.8% |
资本支出强度PPCTHC
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | 6.6% | ||
| Q3 25 | 3.8% | 5.3% | ||
| Q2 25 | 3.3% | 3.7% | ||
| Q1 25 | 2.2% | 3.3% | ||
| Q4 24 | 4.0% | 6.5% | ||
| Q3 24 | 1.9% | 4.2% | ||
| Q2 24 | 2.2% | 2.8% |
现金转化率PPCTHC
| Q1 26 | — | — | ||
| Q4 25 | 3.31× | 1.14× | ||
| Q3 25 | 1.34× | 1.83× | ||
| Q2 25 | 1.39× | 1.79× | ||
| Q1 25 | 0.43× | 1.31× | ||
| Q4 24 | 1.48× | -0.58× | ||
| Q3 24 | 1.86× | 1.53× | ||
| Q2 24 | 2.20× | 1.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PPC
| U.S | $2.6B | 58% |
| Europe | $1.4B | 30% |
| Mexico | $545.5M | 12% |
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |
